Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001974830-24-000001
Filing Date
2024-02-07
Accepted
2024-02-07 13:31:40
Documents
1
Period of Report
2023-02-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 17891
  Complete submission text file 0001974830-24-000001.txt   19514
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Issuer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 236 SILENT MEADOW DRIVE LAKE ST. LOUIS MO 63367
Business Address
Foose Brice (Reporting) CIK: 0001974830 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37350 | Film No.: 24603557